Key points are not available for this paper at this time.
Drug-induced liver injury (DILI) has been a significant challenge in drug discovery, often leading to clinical trial failures and necessitating drug withdrawals. Over the last decade, the existing suite of
Seal et al. (Tue,) studied this question.